Panzolym Otc 20 mg MR tablet
PDF Leaflet Revision Date: 24 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of gastric acid reflux symptoms.
Dosage (summary)
One 20 mg tablet daily in the morning.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; use with caution.
Key Drug Interactions
- HIV protease inhibitors
- Warfarin
- Methotrexate
Contraindications
- Hypersensitivity to pantoprazole
- Severe liver impairment
- Children
Common side effects
- Diarrhoea
- Headache
Counselling Points
- Take before or during breakfast
- Consult doctor if no relief in 2 weeks
- Monitor for signs of hypomagnesaemia
Serious warnings
- Risk of interstitial nephritis
- May mask gastric malignancy symptoms
Important Disclaimer
The Panzolym Otc 20 mg MR tablet professional information leaflet below is the property of Mylan and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
